Science Explorer Back to mapMap
Discussion
Topic · Hematology

Platelet Disorders and Treatments

Platelet Disorders and Treatments is a research topic within Hematology. Science Explorer counts 43k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on platelet disorders, thrombosis mechanisms, and related conditions such as immune thrombocytopenic purpura and von Willebrand disease. It covers topics including platelet function, hemostasis, inflammation, megakaryocyte development, and the molecular mechanisms underlying thrombus formation.

  • Platelets
  • Thrombosis
  • Immune Thrombocytopenic Purpura
  • von Willebrand Disease
  • Hemostasis
  • Inflammation
  • Megakaryocyte Development
  • Thrombus Formation
  • Glycoprotein Iba
  • Vascular Biology
Research works
43k
fractional, since 1950
In the world top 10%
4.3k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+8%
the tick is no change
Largest producer
United States
33% of the 10 largest, 2022-now
Platelet Disorders and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Platelet Disorders and Treatments research?

By volume, the United States and China publish the most (1.5k and 1k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.5k works
  2. 2 China 1k works
  3. 3 Japan 336 works
  4. 4 India 304 works
  5. 5 Germany 302 works
  6. 6 Italy 274 works
  7. 7 France 257 works
  8. 8 United Kingdom 252 works
  9. 9 Canada 176 works
  10. 10 Spain 167 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.6%China: 22.1%Japan: 7.4%India: 6.7%6 others listed: 31.3%33%largest
United States1,484 · 32.6%China1,006 · 22.1%Japan336 · 7.4%India304 · 6.7%6 others listed1,427 · 31.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Platelet Disorders and Treatments research?

By volume in 2022-now, Harvard University publishes the most Platelet Disorders and Treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Inserm.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 77 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 62 works
  3. 3 InsermFrance 49 works
  4. 4 Peking UniversityChina 45 works
  5. 5 Capital Medical UniversityChina 34 works
  6. 6 University of North Carolina at Chapel HillUnited States 33 works
  7. 7 Mayo ClinicUnited States 33 works
  8. 8 Shanghai Jiao Tong UniversityChina 30 works
  9. 9 Soochow UniversityChina 30 works
  10. 10 Cornell UniversityUnited States 30 works

Who are the leading researchers in Platelet Disorders and Treatments?

The most-cited researchers publishing on Platelet Disorders and Treatments include George Davey Smith, Emelia J. Benjamin and Stephan Windecker.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Emelia J. Benjamin United States 341k citations
  3. 3 Stephan Windecker Switzerland 338k citations
  4. 4 Giuseppe Remuzzi Italy 328k citations
  5. 5 Graeme J. Hankey Australia 316k citations
  6. 6 Gordon Henry Guyatt Canada 315k citations
  7. 7 Gregory Y.H. Lip United Kingdom 311k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Platelet Disorders and Treatments?

The most cited paper in Platelet Disorders and Treatments is "Integrins: Versatility, modulation, and signaling in cell adhesion" (Richard O. Hynes, 1992), with 9,972 citations. Next come "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)" (7,231) and "Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen" (5,034).

Most cited papers
#PaperReleasedCitations
1 Integrins: Versatility, modulation, and signaling in cell adhesion Richard O. Hynes · Cell Apr 1992 9,972
2 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) Spiros Miyakis, Michael D. Lockshin, Tatsuya Atsumi et al. · Journal of Thrombosis and Haemostasis Open access 13 Jan 2006 7,231
3 Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen David W. M. Leung, George Cachianes, Wun-Jing Kuang et al. · Science 8 Dec 1989 5,034
4 Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal G. V. R. Born · Nature Jun 1962 4,308
5 Hematological Problems in Pediatric Intensive Care Shoshana Revel‐Vilk, Peter N. Cox, Nancy Robitaille et al. · Pediatric and adolescent medicine Book chapter 28 Nov 2013 3,516
All 100 most cited papers, with filters and sorting

Where is Platelet Disorders and Treatments research done?

The largest centres of Platelet Disorders and Treatments research in 2022-now are Beijing (China), Paris (France), London (United Kingdom) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Milwaukee, Hamilton and Tübingen.

Largest cities, 2022-now

  1. 1 BeijingChina 186 works
  2. 2 ParisFrance 106 works
  3. 3 LondonUnited Kingdom 90 works
  4. 4 TokyoJapan 82 works
  5. 5 ShanghaiChina 81 works
  6. 6 New YorkUnited States 74 works
  7. 7 BostonUnited States 70 works
  8. 8 PhiladelphiaUnited States 63 works
  9. 9 MoscowRussia 63 works
  10. 10 GuangzhouChina 58 works

Where it is the local speciality

  1. MilwaukeeUS · 35.1 works9.3×
  2. HamiltonCA · 31.5 works8.3×
  3. TübingenDE · 21.2 works6.4×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Platelet Disorders and Treatments than the world average.

See Platelet Disorders and Treatments on the map

Where is the best place to study Platelet Disorders and Treatments?

Among universities, judged by research, Harvard University, Medical University of Vienna and McMaster University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 17.53%fractional works in this field (log) →share of work in the world top 10% →Medical University o…Harvard UniversityMcMaster UniversityPeking University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 86.721.6%4.4×77 -1.6%
2Medical University of ViennaAustria 68.222.4%12.3×22 +4.2%
3McMaster UniversityCanada 67.718.6%7.8×25 +7.7%
4Peking UniversityChina 66.015.7%4.0×45 +79.5%
5Universität GreifswaldGermany 64.519.6%20.6×16 +12.0%
6Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 63.210.3%10.7×62 +99.1%
7Cornell UniversityUnited States 62.912.7%4.1×30 +17.2%
8University of PennsylvaniaUnited States 62.218.3%4.5×26 -4.0%
9Imperial College LondonUnited Kingdom 61.618.6%2.7×15 +23.4%
10Erasmus University RotterdamNetherlands 60.517.5%4.7×14 +19.2%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Platelet Disorders and Treatments, country by country

Is Platelet Disorders and Treatments research growing?

Output in 2022-2025 was 8% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Platelet Disorders and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Platelet Disorders and Treatments as a percentage of every work published that year, 0.024% in 2024.

still counting0.050%0.10%Platelet Disorders and Treatments0.027% in 202519801990200020102020

Fractional works of Platelet Disorders and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Platelet Disorders and Treatments10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Platelet Disorders and Treatments. Posts are plain text and can be reported.